September 16, 2013 8:07 AM | 1 min read
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Arena Pharma (NASDAQ: ARNA) today provided an update on Eisai Inc.'s marketing activities forBELVIQ^® (lorcaserin HCl) as the US launch campaign enters its consumer phase.Beginning this month, full-page announcements communicating the availabilityof BELVIQ are being placed in major US magazines, including O, The OprahMagazine. These announcements are intended to educate consumers about BELVIQas a treatment option for weight loss and weight maintenance. In addition,Eisai recently launched the BELIEVE EVERYDAY SUPPORT^SM program to providecomprehensive support and savings for patients treated with BELVIQ. Patientscan enroll in the program at BelieveSupport.com. For Eisai's announcement withadditional details about the program, click here."Patient awareness and education about treatment options is an importantcomponent of the patient/physician relationship," said Jack Lief, Arena'sPresident and Chief Executive Officer. "Eisai's consumer-focused efforts willcomplement their comprehensive healthcare professional education initiativesalready underway."Eisai is responsible for the marketing and distribution of BELVIQ in theUnited States under its agreement with Arena.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.